As of Apr 20
| -0.01 / -0.58%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 3.50, with a high estimate of 10.00 and a low estimate of 1.50. The median estimate represents a +104.68% increase from the last price of 1.71.
The current consensus among 8 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.